Portugal, South Korea and Hungary respectively were numbers 2, 3 and 4 in this ranking.
Our readers also like:
Forecast: Renin-Angiotensin System Medicine Sales in Latvia
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Latvia
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Renin-Angiotensin System Medicine Sales in Latvia
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Latvia
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Use in Latvia
- Units (Defined Daily Dosage) Per Thousand Persons Per Day
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Latvia
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Renin-Angiotensin System Medicine Sales in Latvia
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Latvia
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Latvia
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Renin-Angiotensin System Medicine Sales in Latvia
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
